

In 2023, tuberculosis (TB) returned as the leading infectious disease killer, after falling behind COVID-19 during the pandemic. An estimated 1.25 million lives were lost and 8.2 million new TB cases were reported worldwide, the highest number since the World Health Organization (WHO) began global TB monitoring in 1995.1 These facts reveal the failure to achieve the global commitment made in 2014 through the WHO's End TB Strategy, which set goals of reducing TB incidence by 90% and mortality by 95% by 2035.
Regional Health – Americas
|15th Jan, 2026
|The Lancet
Regional Health – Americas
|15th Jan, 2026
|The Lancet
Regional Health – Americas
|15th Jan, 2026
|The Lancet
Regional Health – Americas
|15th Jan, 2026
|The Lancet
Regional Health – Americas
|15th Jan, 2026
|The Lancet
Regional Health – Americas
|15th Jan, 2026
|The Lancet
Regional Health – Americas
|15th Jan, 2026
|The Lancet